Sven Epple, Ph.D., is an Investigator at GSK, specializing in the design and synthesis of novel nucleic acid therapeutics. With a DPhil from the University of Oxford, Sven developed backbone-modified oligonucleotides and contributed to prestigious journals. Previously, Sven held roles as an oligonucleotide chemist at Biocrucible and a manufacturing scientist at ATDBio, focusing on scale-up and analysis of oligonucleotides. Currently, Sven serves as a Senior Scientist at Roche, leading oligonucleotide lead optimization efforts.
This person is not in the org chart
This person is not in any teams
This person is not in any offices